Company profile KZR

Kezar Life Sciences Inc
kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, includ...ing lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california. Show More
Quarter analysis & expected interestLast update: February 09 2024 07:02:16.

After 39 days of this quarter the interest is at 18.0. Based on that we can calculate that during remaining 52 days it will total up to 42.0.
Kezar Life Sciences expected interest is significantly lower compared to same quarter last year (-52.3%) but similar to previous quarter.

YearQ1Q2Q3Q4
201974
89
20.3% QoQ
124
39.3% QoQ
156
25.8% QoQ
2020 74
0.0% YoY -52.6% QoQ
239
168.5% YoY 223.0% QoQ
158
27.4% YoY -33.9% QoQ
0
-100.0% YoY -100.0% QoQ
2021 99
33.8% YoY inf% QoQ
30
-87.4% YoY -69.7% QoQ
28
-82.3% YoY -6.7% QoQ
39
inf% YoY 39.3% QoQ
2022 112
13.1% YoY 187.2% QoQ
167
456.7% YoY 49.1% QoQ
70
150.0% YoY -58.1% QoQ
101
159.0% YoY 44.3% QoQ
2023 88
-21.4% YoY -12.9% QoQ
200
19.8% YoY 127.3% QoQ
41
-41.4% YoY -79.5% QoQ
50
-50.5% YoY 22.0% QoQ
2024 18
-79.5% YoY -64.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Kezar Life Sciences search interestLast update: February 09 2024 07:02:16.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 07:02:17.

The average 5 years interest of Kezar Life Sciences was 7.5 per week.
The last year interest of Kezar Life Sciences compared to the last 5 years has changed by -6.93%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -23.46%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 07:02:23.

After 39 days of this quarter the interest is at 55.0. Based on that we can calculate that during remaining 52 days it will total up to 128.0.
kezar life sciences stock expected interest is significantly higher compared to previous quarter (+inf%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201949
27
-44.9% QoQ
117
333.3% QoQ
42
-64.1% QoQ
2020 17
-65.3% YoY -59.5% QoQ
124
359.3% YoY 629.4% QoQ
178
52.1% YoY 43.5% QoQ
80
90.5% YoY -55.1% QoQ
2021 92
441.2% YoY 15.0% QoQ
195
57.3% YoY 112.0% QoQ
137
-23.0% YoY -29.7% QoQ
167
108.8% YoY 21.9% QoQ
2022 98
6.5% YoY -41.3% QoQ
88
-54.9% YoY -10.2% QoQ
79
-42.3% YoY -10.2% QoQ
0
-100.0% YoY -100.0% QoQ
2023 166
69.4% YoY inf% QoQ
100
13.6% YoY -39.8% QoQ
17
-78.5% YoY -83.0% QoQ
0
-78.5% YoY -100.0% QoQ
2024 55
-66.9% YoY inf% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and kezar life sciences stock search interestLast update: February 09 2024 07:02:21.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 07:02:25.

The average 5 years interest of kezar life sciences stock was 7.0 per week.
The last year interest of kezar life sciences stock compared to the last 5 years has changed by -24.43%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 17.04%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences news to provide analysis

Correlation between past revenue and kezar life sciences news search interest

There is not enough data for kezar life sciences news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences careers to provide analysis

Correlation between past revenue and kezar life sciences careers search interest

There is not enough data for kezar life sciences careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences pipeline to provide analysis

Correlation between past revenue and kezar life sciences pipeline search interest

There is not enough data for kezar life sciences pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences zetomipzomib to provide analysis

Correlation between past revenue and kezar life sciences zetomipzomib search interest

There is not enough data for kezar life sciences zetomipzomib to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences zetomipzomib to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences immunoproteasome inhibitor to provide analysis

Correlation between past revenue and kezar life sciences immunoproteasome inhibitor search interest

There is not enough data for kezar life sciences immunoproteasome inhibitor to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences immunoproteasome inhibitor to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences clinical trials to provide analysis

Correlation between past revenue and kezar life sciences clinical trials search interest

There is not enough data for kezar life sciences clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences small molecule therapeutics to provide analysis

Correlation between past revenue and kezar life sciences small molecule therapeutics search interest

There is not enough data for kezar life sciences small molecule therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences small molecule therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kezar life sciences immune-mediated diseases... to provide analysis

Correlation between past revenue and kezar life sciences immune-mediated diseases... search interest

There is not enough data for kezar life sciences immune-mediated diseases... to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kezar life sciences immune-mediated diseases... to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for KZR
Earnings date: 2024-03-12 After close
Company name: Kezar Life Sciences Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-14T16:13:00-04:00

PR Newswire
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

2026-04-10T13:34:00-04:00

PR Newswire
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

2026-04-08T14:15:00-04:00

PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

2026-04-07T14:47:00-04:00

PR Newswire
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?

2026-03-31T11:17:00-04:00

PR Newswire
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders?

2026-03-30T13:35:00-04:00

PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)

2026-03-30T12:25:00-04:00

PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders

2026-03-30T12:00:00Z

BusinessWire
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

2026-03-12T13:00:00Z

BusinessWire
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences

2025-11-12T21:01:00Z

BusinessWire
Kezar Life Sciences Reports Third Quarter 2025 Financial Results

2025-11-07T12:01:00Z

BusinessWire
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025

2025-10-17T19:08:03Z

Analyst Upgrades
Jefferies Downgrades Kezar Life Sciences to Hold, Lowers Price Target to $7

2025-10-17T18:38:05Z

Analyst Upgrades
Kezar Launches Strategic Review As FDA Roadblock Derails Liver Drug Plans

2025-10-17T14:22:55Z

Analyst Upgrades
William Blair Downgrades Kezar Life Sciences to Market Perform

2025-10-17T13:01:02Z

Analyst Upgrades
Wells Fargo Maintains Equal-Weight on Kezar Life Sciences, Lowers Price Target to $5